ArticleScientific reports2026
An intelligent ensemble machine learning model for early detection of chronic kidney disease in aging populations.
Article in Scientific reports, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 2 papers.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
2 citing papers in PubMed.
- MLP-CKD: a clinically informed deep learning framework for admission laboratory-based screening and risk stratification of uremia-associated advanced renal dysfunction.Frontiers in public health · 2026Article
- The association between the ZJU index and chronic kidney disease: Evidence from the NHANES and GEO databases.Digital healthArticle
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
6 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Chronic Kidney Disease (CKD) remains a pressing global public health concern, accounting for approximately 1.7 million deaths annually and disproportionately affecting aging and underserved populations. The increasing burden of CKD, particularly in low-resource settings, underscores the urgent need for early, accurate, and scalable diagnostic tools. This study proposes a hybrid mathematical and artificial intelligence (AI) framework for the early prediction of CKD, with a focus on supporting healthcare strategies in aging and resource-limited communities. Utilizing clinical data from a case-control study conducted in District Buner, Khyber Pakhtunkhwa, Pakistan, the framework incorporates a structured modeling pipeline that involves data preprocessing (feature extraction, missing data imputation, and categorical encoding) and class balancing via the Synthetic Minority Over-Sampling Technique (SMOTE). The proposed system integrates multiple machine learning algorithms, including logistic regression, feedforward neural networks, decision trees, support vector machines, and random forests, within a novel ensemble learning strategy designed to enhance diagnostic precision. Model robustness was assessed using three distinct train–test scenarios: (90%, 10%), (75%, 25%), and (50%, 50%). Performance evaluation employed six metrics: accuracy, specificity, sensitivity, Youden index, Brier score, and F1 score, supported by comprehensive graphical and statistical analysis. The ensemble model consistently outperformed individual classifiers, achieving a mean accuracy of 97.71%, specificity of 97.19%, sensitivity of 99.84%, Youden index of 86.55, Brier score of 1.43%, and F1 score of 98.19%. Support vector machines and random forests ranked second and third, respectively, while decision trees exhibited the lowest performance. To the best of our knowledge, this is the first ensemble-based predictive framework for CKD developed using clinical data from Pakistan. The system holds strong potential for integration into real-world biomedical decision support systems, particularly in aging and underserved populations, thereby contributing to early detection, enhanced care delivery, and optimized resource utilization in the management of chronic diseases.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.